Belge G, Grobelny F, Radtke A, Bodes J, Matthies C, Wülfing C, Dieckmann KP (2020) Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin. J Cancer Res Clin Oncol 147:435–443

Article  PubMed  PubMed Central  Google Scholar 

Belge G, Dumlupinar C, Nestler T, Klemke M, Törzsök P, Trenti E, Pichler R, Loidl W, Che Y, Hiester A, Matthies C, Pichler M, Paffenholz P, Kluth L, Wenzel M, Sommer J, Heinzelbecker J, Schriefer P, Winter A, Zengerling F, Kramer MW, Lengert M, Frey J, Heidenreich A, Wülfing C, Radtke A, Dieckmann KP (2024) Detection of recurrence through microRNA-371a-3p serum levels in a follow-up of stage I testicular germ cell tumors in the DRKS-00019223 study. Clin Cancer Res 30:404–412

Article  CAS  PubMed  Google Scholar 

Dieckmann KP, Anheuser P, Simonsen H, Höflmayer D (2017a) Pure testicular seminoma with non-pathologic elevation of alpha fetoprotein: a Case Series. Urol Int 99:353–357

Article  CAS  PubMed  Google Scholar 

Dieckmann KP, Radke A, Spiekermann M, Balks T, Matthies C, Becker P, Ruf C, Oing C, Oechsle K, Bokemeyer C, Hammel J, Melchior S, Wosniok W, Belge G (2017b) Serum levels of MicroRNA 371a-3p: a sensitive and specific new biomarker for germ cell tumors. Eur Urol 71:213–220

Article  CAS  PubMed  Google Scholar 

Dieckmann KP, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Haben B, Loidl W, Ruf CG, Heinzelbecker J, Heidenreich A, Cremers JF, Oing C, Hermanns T, Fankhauser CD, Gillessen S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Belge G (2019) Serum levels of microRNA-371a-3p (M371 test) as a new biomarker of testicular germ cell-tumors: results of a prospective multicentric study. J Clin Oncol 37:1412–1423

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fankhauser CD, Christiansen AJ, Rothermundt C, Cathomas R, Wettstein MS, Grossmann NC, Grogg JB, Templeton AJ, Hirschi-Blickenstorfer A, Lorch A, Gillessen S, Moch H, Beyer J, Hermanns T (2022) Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours. Br J Cancer 126:1140–1144

Article  CAS  PubMed  Google Scholar 

Guo H, Ji F, Zhao X, Yang X, He J, Huang L, Zhang Y (2019) MicroRNA-371a-3p promotes progression of gastric cancer by targeting TOB1. Cancer Lett 443:179–188

Article  CAS  PubMed  Google Scholar 

Lafin JT, Singla N, Woldu SL, Lotan Y, Lewis CM, Majmudar K, Savelyeva A, Kapur P, Margulis V, Strand DW, Murray MJ, Amatruda JF, Bagrodia A (2020) Serum MicroRNA-371a-3p levels predict viable germ cell tumor in Chemotherapy-naïve patients undergoing Retroperitoneal Lymph Node Dissection. Eur Urol 77:290–292

Article  CAS  PubMed  Google Scholar 

Laï JL, Zandecki M, Mary JY, Bernardi F, Izydorczyk V, Flactif M, Morel P, Jouet JP, Bauters F, Facon T (1995) Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood 85:2490–2497

Article  PubMed  Google Scholar 

Lange PH, Winfield HN (1987) Biological markers in urologic cancer. Cancer 60:464–472

Article  CAS  PubMed  Google Scholar 

Lani L, Stefanini B, Trevisani F (2024) Surveillance for Hepatocellular Carcinoma in patients with successfully treated viral disease of the liver: a systematic review. Liver Cancer 13:376–388

Article  PubMed  PubMed Central  Google Scholar 

Leão R, Albersen M, Looijenga LHJ, Tandstad T, Kollmannsberger C, Murray MJ, Culine S, Coleman N, Belge G, Hamilton RJ, Dieckmann KP (2021) Circulating MicroRNAs, the Next-Generation serum biomarkers in testicular germ cell tumours: a systematic review. Eur Urol 80:456–466

Article  PubMed  Google Scholar 

Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408

Article  CAS  PubMed  Google Scholar 

Lobo J, Leão R, Gillis AJM, van den Berg A, Anson-Cartwright L, Atenafu EG, Kuhathaas K, Chung P, Hansen A, Bedard PL, Jewett MAS, Warde P, O’Malley M, Sweet J, Looijenga LHJ, Hamilton RJ (2021) Utility of serum miR-371a-3p in Predicting Relapse on Surveillance in patients with clinical stage I testicular germ cell Cancer. Eur Urol Oncol 4:483–491

Article  PubMed  Google Scholar 

Mohamed AN, Bentley G, Bonnett ML, Zonder J, Al-Katib A (2007) Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes. Am J Hematol 82:1080–1087

Article  PubMed  Google Scholar 

Nilsson T, Höglund M, Lenhoff S, Rylander L, Turesson I, Westin J, Mitelman F, Johansson B (2003) A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age- and sex-related differences. Br J Haematol 120:960–699

Article  PubMed  Google Scholar 

Pedrazzoli P, Rosti G, Soresini E, Ciani S, Secondino S (2021) Serum tumour markers in germ cell tumours: from diagnosis to cure. Crit Rev Oncol Hematol 159:103224

Article  PubMed  Google Scholar 

Radtke A, Hennig F, Ikogho R, Hammel J, Anheuser P, Wülfing C, Belge G, Dieckmann KP (2018) The Novel Biomarker of Germ Cell Tumours, Micro-RNA-371a-3p, has a very Rapid Decay in patients with clinical stage 1. Urol int 100:470–475

Article  CAS  PubMed  Google Scholar 

Rippe V, Dittberner L, Lorenz VN, Drieschner N, Nimzyk R, Sendt W, Junker K, Belge G, Bullerdiek J (2010) The two stem cell MicroRNA gene clusters C19MC and mir-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas. PlosOne PLoS One 5:e9485

Article  Google Scholar 

Seales CL, Puri D, Yodkhunnatham N, Pandit K, Yuen K, Murray S, Smitham J, Lafin JT, Bagrodia A (2024) Advancing GCT management: a review of miR-371a-3p and other miRNAs in comparison to traditional serum tumor markers. Cancers (Basel) 16:1379

Article  CAS  PubMed  Google Scholar 

Seelemeyer F, Pfister D, Pappesch R, Merkelbach-Bruse S, Paffenholz P, Heidenreich A (2024) Evaluation of a miRNA-371a-3p assay for Predicting final histopathology in patients undergoing primary nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. Eur Urol Oncol 7:319–322

Article  PubMed  Google Scholar 

Shah JA, Khattak S, Rauf MA, Cai Y, Jin J (2021) Potential biomarkers of mir-371-373 gene cluster in Tumorigenesis. Life (Basel) 11:984

CAS  PubMed  Google Scholar 

Spiekermann M, Belge G, Winter N, Ikogho R, Balks T, Bullerdiek J, Dieckmann KP (2015) MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker. Andrology 3:78–84

Article  CAS  PubMed  Google Scholar 

Syring I, Bartels J, Holdenrieder S, Kristiansen G, Müller SC, Ellinger J (2015) Circulating serum microRNA (miR-367-3p, miR-371a-3p, miR-372-3p, miR-373-3p) as biomarkers for patients with testicular germ cell cancers. J Urol 193:331–337

Article  CAS  PubMed  Google Scholar 

Takizawa A, Kawai K, Kawahara T, Kojima T, Maruyama S, Shinohara N, Akamatsu S, Kamba T, Nakamura T, Ukimura O, Jikuya R, Kishida T, Kakimoto K, Nishimura K, Harabayashi T, Nagamori S, Yamashita S, Arai Y, Sawada Y, Sekido N, Kinoshita H, Matsuda T, Nakagawa T, Homma Y, Nishiyama H (2017) The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor. J Cancer Res Clin Oncol 144:109–115

Article  PubMed  Google Scholar 

van Agthoven T, Looijenga LH (2017) Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test). Oncotarget 8:58037–58049

Article  PubMed  Google Scholar 

Wang J, Dong S, Zhang J, Jing D, Wang W, Dong L, Zhao Y (2020) LncRNA NR2F1-AS1 regulates miR-371a-3p/TOB1 Axis to suppress proliferation of Colorectal Cancer cells. Cancer Biother Radiopharm 35:760–764

CAS  PubMed  Google Scholar